Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

Name: Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study
Creator: April Armstrong
Published: 2026-01-15T21:04:17.164Z
Keywords: Atopic Dermatitis

Armstrong, April; gooderham, melinda; Eyerich, Kilian; Reich, Kristian; Blauvelt, Andrew; Hong, H. Chih-ho; Edwards, Roger A.; Bonfanti, Gianluca; Clibborn, Claire; Biswas, Pinaki; Chan, Gary; Feeney, Claire; guler, erman

doi:10.17632/gcf3f9mwnc.1

Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

Published: 15 January 2026| Version 1 | DOI: 10.17632/gcf3f9mwnc.1

Contributors:

April Armstrong, melinda gooderham, Kilian Eyerich, Kristian Reich, Andrew Blauvelt, H. Chih-ho Hong, Roger A. Edwards, Gianluca Bonfanti, Claire Clibborn, Pinaki Biswas, Gary Chan, Claire Feeney, erman guler

Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study

Description

Files

Categories

Funders

Licence